Atopic Dermatitis

A dermatologist and a patient discuss the importance of having a multidisciplinary team approach to treating atopic dermatitis.

Researchers found that the Comfiknit Atopic Eczema T-shirt reduced Eczema Area and Severity Index scores.

Peter Lio, MD, discusses pearls and takeaways from the atopic dermatitis panel he participated in at the 2023 Society of Pediatric Dermatology meeting.

Diego Ruiz Dasilva, MD, FAAD, and Trinity Flint discuss early treatment of her atopic dermatitis, focusing on topical treatment.

Trinity Flint comments on the burden of atopic dermatitis, highlighting its impact on her social life as a child and teen.

Christopher Bunick, MD, PhD, introduces an integrated analysis of phase three studies analyzing the long-term safety of upadacitinib as treatment for atopic dermatitis (AD). He also highlights a burgeoning standard to assess the safety of treatment.

Ruth Ann Vleugels, MD, MPD, MBA, and Christopher Bunick, MD, PhD, provide their clinical experience with Janus Kinase (JAK) inhibitors and the importance of patient compliance with these agents.

Researchers found that treatment for atopic dermatitis could contribute to a higher mutation rate.

Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.

Diego Ruiz Dasilva, MD, FAAD, reviews the difference between clinical presentation of atopic dermatitis in adults vs children, as well as the pathophysiology of the disease.

Trinity Flint, a patient with atopic dermatitis, talks about the initial symptoms she had as a child that led her to see a doctor for diagnosis.

Compared to patients who identified as heterosexual, patients in the LGBTQ+ community have a higher prevalence of atopic dermatitis, asthma, and allergic rhinitis.

Experts discuss a recent network meta-analysis comparing current monotherapies for atopic dermatitis (AD) and how this may change standards of care.

Christopher Bunick, MD, PhD, and Ruth Ann Vleugels, MD, MPD, MBA, discuss the method of action for Janus Kinase (JAK) inhibitors and the pathology of atopic dermatitis (AD).

Researchers conducted a systematic review and meta-analysis of probiotic treatment efficacy in children with atopic dermatitis.

Clinicians James Q. Del Rosso, DO; Raj Chovatiya, MD, PhD; and Lisa Swanson, MD, PhD, review the study, “Rapid Pruritus Reduction With Ruxolitinib Cream in Patients With Atopic Dermatitis."

Experts discuss prospective therapies on the horizon for atopic dermatitis (AD).

Children of mothers who took more than 5 courses of antibiotics during pregnancy were at the highest risk.

Experts offer their clinical experience on preventing patient withdrawal and breaking the atopic dermatitis (AD) disease cycle.

Adam Friedman, MD, FAAD, and Andrew Alexis, MD, MPH, discuss disparities in atopic dermatitis and the ways these can be addressed with teledermatology.

In a Dermatology Times DermView custom video series, Shawn Kwatra, MD, and Peter Lio, MD, discuss the topical treatment landscape of atopic dermatitis.

Pediatricians are often the first to diagnose and manage pediatric atopic dermatitis, and Larry Eichenfield, MD, led a team to develop a tool to help them.

Peter Lio, MD also explained why he considers it a bad day when he does not learn something new about this disease.

AB-101a is a new topical treatment being investigated for mild, moderate, and severe atopic dermatitis and its immune system component.

Peter Lio, MD, FAAD, discusses how body surface area of atopic dermatitis (AD) affects topical treatment options.